Page 51 - Critical Path News Today

"I think our goals are more ambitious this time, and I think our focus will be tighter."

Sign up for the GI Daily here to get the biggest news straight to your inbox Phoenix Labs alum Jeanne-Marie Owens and J…

I view much of what’s happened in critical path method (CPM) scheduling and planning as a direct offspring of the ENR cover story, “Off the Critical Path,” published in 2003.

Join us live in Dubai at the World Bank Group pavilion, in partnership with the IMF and the FT, and online. Follow the conversation with #LivablePlanet.

Our Smartsheet review shows it's great for fast-growing businesses looking to manage multiple projects, but not so much for big enterprises.

Join us for an interactive and dynamic panel to discuss how art can be a powerful tool in rebuilding communities by promoting healing, unity, economic growth, cultural preservation, and social change. It provides a means for individuals to connect, express themselves, and envision a more positive and resilient future. Panelists: 

Tulane University is a comprehensive research university in New Orleans, Louisiana. Tulanians see challenges as opportunities, and strive to improve the lives of others in our own community and around the globe.

Critical Path Institute (C-Path) is pleased to announce the release of a new peer-reviewed publication, titled "Transforming Drug Development for Neurological Disorders: Proceedings from a Multi-disease Area Workshop," now published in Neurotherapeutics, The Journal of the American Society for Experimental Neurotherapeutics.

Bill McGlashan, a notable name within the impact investing space, is confident that this doesn't have to be the case. Building on over three decades of experience in private equity investing, McGlashan has been a steward of the impact investing movement. He is the co-founder of The Rise Fund, one of the seminal impact investing funds that made history as being the largest ever raised, and also founded Y Analytics, a social enterprise with a mission of creating standardized metrics for socia...

/PRNewswire/ -- Today, the National Organization for Rare Disorders (NORD®) launched a new education series in English and Spanish titled, "Rare Disease Drug...